# Study of TV-1106 in Growth Hormone-Deficient Adults

> **NCT02410343** · PHASE3 · TERMINATED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 14 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** TV-1106
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02410343
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04-30
- **Primary completion:** 2015-12-31
- **Final completion:** 2015-12-31
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02410343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02410343, "Study of TV-1106 in Growth Hormone-Deficient Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02410343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*